The system includes Biostat Biologx Fibrin Sealant, which is a human derived, biologic tissue sealant. It also includes the Biostat Delivery Device, which is designed for safe delivery of biologic materials to the intervertebral disc.
The company initiated a Phase III study of the system in March 2010, which is currently still enrolling subjects at 20 centers across the country.
Related Articles on Spine Devices:
VG Innovations Launches Spinal System for Low Back Pain
Crosstrees Medical Obtains U.S. Patent for Spinal Disc Therapy
Captiva Spine Ramping UP Production of TLIF Device After Receiving Patents
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.